X
Dan Lichtman
Founding President and CEO
Following through with his passion to develop better diagnostic tools, Dan Lichtman applied his 20 years of experience as the President and CEO of a successful distributorship of immuno-diagnostic reagents and instruments to form NoAb Diagnostics in 1995. In 2001, Dan added the drug discovery focus and changed the company's name to NoAb BioDiscoveries to better reflect this direction. Dan is committed to growing NoAb BioDiscoveries into a premier drug discovery company.
David K. H. Lee, Ph.D.
Chief Scientific Officer
With over 25 years in the pharmaceutical industry, David joined NoAb BioDiscoveries in October 2001. Prior to that, he was the founding President of Maxxam BioDiscoveries Inc., a drug discovery service organization. David has also worked at Wyeth Laboratories, Johnson & Johnson Pharmaceutical Research and Development LLC, and Allelix Biopharmaceuticals. In his present position, David leads the growth of NoAb BioDiscoveries through the development of technologies and business development.
Cathy Trewin, C.A.
Chief Financial Officer
Cathy Trewin brought her 15 years of experience to NoAb BioDiscoveries in October 2000. With a background in the manufacturing, distribution, laboratory services and public accounting industries, Cathy now holds overall responsibility for finance, information technology, and human resource services. She is a member of the Ontario Institute of Chartered Accountants and has a Bachelor of Commerce degree from the University of Toronto. Cathy also serves as CFO for Inter Medico.
Inés de Lannoy, Ph.D.
Senior Director, Research and Development
Inés joined NoAb BioDiscoveries in 2002. Prior to joining NoAb, she was Director of Research at Maxxam BioDiscoveries, where she helped build HTS, ADMET and PK capabilities as a service to pharmaceutical clients. Inés is a well respected pharmacokineticist who has been instrumental in building the pharmacokinetics capabilities of several companies. Previously at Allelix Biopharmaceuticals Inés advanced several drug candidates from discovery into clinical trials. Inés provides leadership in all aspects of PK and continues to develop key PK models and tools.
Marc Frigault.
Director, Research Administration
Marc joined NoAb BioDiscoveries in August 2010. He brings with him over 8 years of management experience in the clinical research field acquired through positions held at Innovaderm Research, Biovail Contract Research and Cetero Research where he was primarily responsible for heading the successful patient recruitment and screening operations. He is a Certified Clinical Research Professional and holds a Bachelor of Science degree from the University of Moncton. In his current position, Marc provides leadership to the operations team in support of client-sponsored drug discovery research efforts.
